Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.

about

Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.

Item

http://www.wikidata.org/entity/Q36303841

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@ast

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@en

type

Item

label

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@ast

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@en

prefLabel

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@ast

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@en

P1476

Allogeneic hematopoietic stem- ...... metastatic renal cell cancer.

@en

P2093

David Chao

http://www.w3.org/2001/XMLSchema#string

Hitendra R H Patel

http://www.w3.org/2001/XMLSchema#string

Manit Arya

http://www.w3.org/2001/XMLSchema#string

P2860

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.

Systemic therapy for renal cell carcinoma.

Progress in human tumour immunology and immunotherapy.

Renal-cell carcinoma.

Kidney cancer.

Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach.

In situ demonstration of renal-cell-carcinoma-specific T-cell clones.

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.

P304

32-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPONC0019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16264797

http://www.w3.org/2001/XMLSchema#string